Manufacturers Life Insurance Company, The Dynavax Technologies Corp Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 66,756 shares of DVAX stock, worth $856,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,756
Previous 67,854 1.62%
Holding current value
$856,479
Previous $762,000 2.49%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$10.05 - $11.61 $11,034 - $12,747
-1,098 Reduced 1.62%
66,756 $743,000
Q2 2024

Aug 14, 2024
BUY
$10.73 - $12.58 $43,660 - $51,188
4,069 Added 6.38%
67,854 $762,000
Q1 2024

May 14, 2024
SELL
$11.7 - $14.98 $2,948 - $3,774
-252 Reduced 0.39%
63,785 $791,000
Q4 2023

Feb 13, 2024
SELL
$13.09 - $14.98 $14,582 - $16,687
-1,114 Reduced 1.71%
64,037 $895,000
Q3 2023

Nov 15, 2023
BUY
$12.64 - $14.99 $165,609 - $196,398
13,102 Added 25.17%
65,151 $962,000
Q2 2023

Aug 11, 2023
BUY
$9.85 - $13.17 $44,216 - $59,120
4,489 Added 9.44%
52,049 $672,000
Q1 2023

May 15, 2023
BUY
$9.44 - $11.88 $1,850 - $2,328
196 Added 0.41%
47,756 $468,000
Q4 2022

Aug 11, 2023
BUY
$10.27 - $13.29 $7,651 - $9,901
745 Added 1.59%
47,560 $506,000
Q4 2022

Feb 13, 2023
BUY
$10.27 - $13.29 $7,651 - $9,901
745 Added 1.59%
47,560 $506,000
Q3 2022

Aug 11, 2023
SELL
$9.93 - $17.44 $8,619 - $15,137
-868 Reduced 1.82%
46,815 $488,000
Q3 2022

Nov 03, 2022
SELL
$9.93 - $17.44 $8,619 - $15,137
-868 Reduced 1.82%
46,815 $489,000
Q2 2022

Aug 11, 2023
BUY
$7.45 - $12.83 $22,700 - $39,093
3,047 Added 6.83%
47,683 $600,000
Q2 2022

Aug 15, 2022
BUY
$7.45 - $12.83 $22,700 - $39,093
3,047 Added 6.83%
47,683 $600,000
Q1 2022

Aug 11, 2023
SELL
$9.75 - $14.44 $30,420 - $45,052
-3,120 Reduced 6.53%
44,636 $483,000
Q1 2022

May 20, 2022
SELL
$9.75 - $14.44 $99,372 - $147,172
-10,192 Reduced 18.59%
44,636 $484,000
Q4 2021

Feb 16, 2022
SELL
$13.17 - $20.94 $9,271 - $14,741
-704 Reduced 1.27%
54,828 $771,000
Q3 2021

Nov 12, 2021
SELL
$9.16 - $19.83 $47,696 - $103,254
-5,207 Reduced 8.57%
55,532 $1.07 Million
Q2 2021

Aug 12, 2021
BUY
$7.25 - $10.99 $7,119 - $10,792
982 Added 1.64%
60,739 $598,000
Q1 2021

May 03, 2021
SELL
$4.57 - $11.18 $20,418 - $49,952
-4,468 Reduced 6.96%
59,757 $587,000
Q4 2020

Feb 12, 2021
BUY
$3.73 - $5.6 $15,956 - $23,956
4,278 Added 7.14%
64,225 $286,000
Q3 2020

Nov 09, 2020
BUY
$4.32 - $11.7 $28,270 - $76,564
6,544 Added 12.25%
59,947 $259,000
Q2 2020

Aug 10, 2020
SELL
$2.94 - $9.1 $3,319 - $10,273
-1,129 Reduced 2.07%
53,403 $453,000
Q1 2020

May 15, 2020
BUY
$2.27 - $6.2 $9,077 - $24,793
3,999 Added 7.91%
54,532 $192,000
Q4 2019

Feb 14, 2020
SELL
$3.46 - $6.93 $1,207 - $2,418
-349 Reduced 0.69%
50,533 $289,000
Q3 2019

Nov 12, 2019
BUY
$2.69 - $4.85 $19,072 - $34,386
7,090 Added 16.19%
50,882 $180,000
Q2 2019

Aug 14, 2019
BUY
$3.65 - $7.89 $4,759 - $10,288
1,304 Added 3.07%
43,792 $175,000
Q1 2019

May 13, 2019
BUY
$7.08 - $12.09 $24,036 - $41,045
3,395 Added 8.68%
42,488 $311,000
Q4 2018

Feb 14, 2019
SELL
$8.14 - $13.28 $21,066 - $34,368
-2,588 Reduced 6.21%
39,093 $358,000
Q3 2018

Nov 14, 2018
SELL
$11.85 - $16.0 $117,172 - $158,208
-9,888 Reduced 19.17%
41,681 $517,000
Q2 2018

Aug 14, 2018
BUY
$15.15 - $20.75 $24,512 - $33,573
1,618 Added 3.24%
51,569 $787,000
Q1 2018

May 15, 2018
BUY
$14.65 - $19.9 $32,742 - $44,476
2,235 Added 4.68%
49,951 $992,000
Q4 2017

Feb 08, 2018
SELL
$17.3 - $24.08 $4,774 - $6,646
-276 Reduced 0.58%
47,716 $892,000
Q3 2017

Nov 14, 2017
BUY
$15.2 - $21.5 $729,478 - $1.03 Million
47,992
47,992 $1.03 Million

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email